<html>
<head>PUBMED IDs for CGL4</head>
<body bgcolor='#C5F0F2'><h1>CGL4</h1><a href='https://pubmed.ncbi.nlm.nih.gov/2304898/'>Identification of the HeLa tumor-associated antigen, p75/150, as intestinal alkaline phosphatase and evidence for its transcriptional regulation.</a> February 1  1990<br><a href='https://pubmed.ncbi.nlm.nih.gov/9685730/'>Reduction of caveolin-1 expression in tumorigenic human cell hybrids.</a> August 1  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10213483/'>Tumorigenic conversion resulting from inhibition of apoptosis in a nontumorigenic HeLa-derived hybrid cell line.</a> April 23  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10336639/'>Enhanced expression of glucose transporter GLUT3 in tumorigenic HeLa cell hybrids associated with tumor suppressor dysfunction.</a> May 21  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/18763137/'>Dimerization of two novel apoptosisinducing proteins and its function in regulating cell apoptosis.</a> September 3  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20300641/'>Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations.</a> April 23  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20638880/'>A Japanese child with asymptomatic elevation of serum creatine kinase shows PTRF-CAVIN mutation matching with congenital generalized lipodystrophy type 4.</a> January 29  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20684003/'>Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations.</a> December 16  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/25721873/'>Novel nonsense mutation in the PTRF gene underlies congenital generalized lipodystrophy in a consanguineous Saudi family.</a> January 29  2015<br></body></html>
